0.6456

7.24% 0.0436

After Hours: .65 0.0044 +0.68%

Geovax Labs Inc (GOVX)

Overview News Price History Financials Discussions Forecast Stock Split

Geovax Labs Inc stock is traded at $0.6456, with a volume of 639.09K. It is up +7.24% in the last 24 hours and down -35.12% over the past month. Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

Previous Close:

$0.602

Open:

$0.6294

24h Volume:

639.09K

Relative Volume:

0.36

Market Cap:

$3.36M

Revenue:

$852.30K

Net Income/Loss:

$-21.37M

P/E Ratio:

-0.0298

EPS:

-21.6981

Net Cash Flow:

$-19.06M

1W Performance:

-10.08%

1M Performance:

-35.12%

6M Performance:

-57.80%

1Y Performance:

-96.56%

1-Day Range:

$0.6125

$0.659

1-Week Range:

$0.59

$0.7779

52-Week Range:

$0.59

$20.00

Geovax Labs Inc Stock (GOVX) Company Profile

Name

Geovax Labs Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

678-384-7220

Address

1955 LAKE PARK DRIVE, SMYRNA

Employee

Twitter

Next Earnings Date

2026-07-27

Latest SEC Filings

GOVX's Discussions on Twitter

Compare GOVX vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GOVX Geovax Labs Inc	0.6456	3.14M	852.30K	-21.37M	-19.06M	-21.70
VRTX Vertex Pharmaceuticals Inc	548.05	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	834.04	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,039.78	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.13	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.46	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-19-26	Downgrade	D. Boral Capital	Buy → Hold
Apr-15-25	Reiterated	Alliance Global Partners	Buy
Apr-15-25	Reiterated	D. Boral Capital	Buy
Nov-11-24	Initiated	Alliance Global Partners	Buy
Jul-16-24	Initiated	ROTH MKM	Buy
Nov-19-20	Initiated	Maxim Group	Buy

View All

Geovax Labs Inc Stock (GOVX) Latest News

Aug 20, 2026

Why Is GOVX Stock Falling Today? - Stocktwits

Aug 20, 2026

GeoVax Chairman and CEO David Dodd to Participate in 2026 Georgia Life Sciences Summit - Yahoo Finance

Aug 20, 2026

Aug 19, 2026

GeoVax (GOVX) Financial Results: The Available Earnings Metric Delivers a Beat at the Close; Price Move: Shares Move 0.86% DownRevenue Estimate Trend - vinanet.vn

Aug 19, 2026

Aug 17, 2026

GOVX Stock Became A Hot Biodefense Trade Amid Ebola, Hantavirus Concerns - Stocktwits

Aug 17, 2026

Aug 14, 2026

GeoVax Labs (GOVX): Armistice Capital and Steven Boyd disclose 4.99% stake - Stock Titan

Aug 14, 2026

Aug 13, 2026

GeoVax Labs (GOVX) holders report 1.59% stake tied to 118,715 warrants - Stock Titan

Aug 13, 2026

GeoVax Highlights Capabilities Amid Congo's Expanding Ebola Outbreak - Yahoo Finance

Aug 13, 2026